Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

46
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
46
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

69
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Folate receptor alpha, TROP2 and HER2 in high-grade serous ovarian Cancer: Expression and clinicopathological correlations.

Gynecologic oncology·2026
Same author

Acylhydrazone-Functionalized Waterborne Polyurethane Coating: An Intelligent Protective Material Integrating High Strength and Toughness, Self-Healing and Acid-Responsive Fluorescence.

ACS macro letters·2026
Same author

When MicroRNAs meet hypoxic pulmonary hypertension.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

A Single lncRNA-Initiated Multiple Rolling Circle Amplification Based on Proximity Hybridization for One-Step Ratiometric Fluorescence Detection of lncRNAs in Breast Cancer.

Analytical chemistry·2026
Same author

Circulating microRNAs in viral myocarditis: Advancements in biological understanding and potential clinical applications.

Gene·2025
Same author

Exocarpium Citri Grandis ameliorates alcoholic liver disease by modulation of hepatic lipid metabolism and iron homeostasis.

Chinese medicine·2025

Related Experiment Video

Updated: May 9, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K

Molecular mechanisms of pyroptosis in non-alcoholic steatohepatitis and feasible diagnosis and treatment strategies.

Dong-Fang Shang1, Wen-Qian Xu2, Qing Zhao3

  • 1Henan University of CM, Zhengzhou 450000, China; The First Affiliated Hospital of Henan University of CM, Zhengzhou 450003, China.

Pharmacological Research
|April 30, 2025
PubMed
Summary

Pyroptosis, a cell death form, drives inflammation and is key in non-alcoholic steatohepatitis (NASH) development. Targeting pyroptosis offers new diagnostic and therapeutic strategies for NASH.

Keywords:
Diagnosis and Treatment StrategiesMolecular MechanismsNASHPersonalized MedicinePyroptosis

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K
Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

8.7K

Related Experiment Videos

Last Updated: May 9, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K
Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

8.7K

Area of Science:

  • Cell biology
  • Immunology
  • Hepatology

Background:

  • Pyroptosis is a pro-inflammatory programmed cell death pathway.
  • Key mediators include gasdermin and pannexin-1 proteins.
  • Pyroptosis is implicated in various inflammatory conditions.

Purpose of the Study:

  • To review the molecular mechanisms of pyroptosis.
  • To elucidate the role of pyroptosis in non-alcoholic steatohepatitis (NASH) pathogenesis.
  • To explore pyroptosis-targeting strategies for NASH diagnosis and treatment.

Main Methods:

  • Literature review of pyroptosis pathways and NASH.
  • Analysis of molecular mechanisms linking pyroptosis to NASH.
  • Exploration of potential therapeutic targets.

Main Results:

  • Pyroptosis contributes to inflammatory responses in NASH.
  • Interactions between pyroptosis, immunity, lipotoxicity, ER stress, and microbiota drive NASH.
  • Gasdermin and pannexin-1 are crucial effectors.

Conclusions:

  • Pyroptosis is a significant factor in NASH pathogenesis.
  • Targeting pyroptosis presents promising avenues for NASH management.
  • Further research into pyroptosis mechanisms can improve NASH treatment.